| Study title |
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study |
| Disease or condition |
NASH |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Lisinopril, open label |
| Phase |
2 |
| Study site |
Duke University |
| Study location |
Durham |
| Principal investigator name and email |
Cynthia Moylan, MD |
| Study coordinator name and email |
Magdi Elgasim, magdi.elgasim@duke.edu |
| Phone contact |
919-684-9019 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04550481 |
